These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 28958895)
21. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation. Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K Front Immunol; 2018; 9():109. PubMed ID: 29456530 [TBL] [Abstract][Full Text] [Related]
22. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study. Bonifazi F; Solano C; Wolschke C; Sessa M; Patriarca F; Zallio F; Nagler A; Selleri C; Risitano AM; Messina G; Bethge W; Herrera P; Sureda A; Carella AM; Cimminiello M; Guidi S; Finke J; Sorasio R; Ferra C; Sierra J; Russo D; Benedetti E; Milone G; Benedetti F; Heinzelmann M; Pastore D; Jurado M; Terruzzi E; Narni F; Völp A; Ayuk F; Ruutu T; Kröger N Lancet Haematol; 2019 Feb; 6(2):e89-e99. PubMed ID: 30709437 [TBL] [Abstract][Full Text] [Related]
23. Comparing between HLA-matched sibling donor allogenic HSCT and non-sibling matched related donor allogenic HSCT outcome in pediatric patients; single center retrospective study. Essa MF; Alghazwani S; Abujoub R; Memon S; Alkaiyat M; Ardah H; Alsultan A Pediatr Transplant; 2024 Feb; 28(1):e14692. PubMed ID: 38317341 [TBL] [Abstract][Full Text] [Related]
24. Efficiency of allogeneic hematopoietic SCT from HLA fully-matched non-sibling relatives: a new prospect of exploiting extended family search. Hamidieh AA; Dehaghi MO; Paragomi P; Navaei S; Jalali A; Eslami GG; Behfar M; Ghavamzadeh A Bone Marrow Transplant; 2015 Apr; 50(4):545-52. PubMed ID: 25621800 [TBL] [Abstract][Full Text] [Related]
25. Mismatch on glutathione S-transferase T1 increases the risk of graft-versus-host disease and mortality after allogeneic stem cell transplantation. Martínez-Bravo MJ; Calderón-Cabrera C; Márquez-Malaver FJ; Rodríguez N; Guijarro M; Espigado I; Núñez-Roldán A; Pérez-Simón JA; Aguilera I Biol Blood Marrow Transplant; 2014 Sep; 20(9):1356-62. PubMed ID: 24844856 [TBL] [Abstract][Full Text] [Related]
26. HLA-DPB1 mismatch and acute graft-versus host disease in HLA-identical sibling donors. Mosaad YM; Kamel H Egypt J Immunol; 2005; 12(2):21-8. PubMed ID: 17977207 [TBL] [Abstract][Full Text] [Related]
27. Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting. Afram G; Simón JAP; Remberger M; Caballero-Velázquez T; Martino R; Piñana JL; Ringden O; Esquirol A; Lopez-Corral L; Garcia I; López-Godino O; Sierra J; Caballero D; Ljungman P; Vazquez L; Hägglund H Med Oncol; 2018 Apr; 35(6):79. PubMed ID: 29696461 [TBL] [Abstract][Full Text] [Related]
28. Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation. Zhou H; Bao X; Wu X; Tang X; Wang M; Wu D; He J Biol Blood Marrow Transplant; 2014 Jan; 20(1):98-105. PubMed ID: 24516895 [TBL] [Abstract][Full Text] [Related]
29. The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor hematopoietic stem cell transplantation for myeloid malignancies. Wang H; He Y; Zhai WJ; Wang M; Zhou Z; Zhao YX; Feng SZ; Han MZ Swiss Med Wkly; 2013; 143():w13717. PubMed ID: 23299929 [TBL] [Abstract][Full Text] [Related]
30. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Zecca M; Prete A; Rondelli R; Lanino E; Balduzzi A; Messina C; Fagioli F; Porta F; Favre C; Pession A; Locatelli F; Blood; 2002 Aug; 100(4):1192-200. PubMed ID: 12149197 [TBL] [Abstract][Full Text] [Related]
31. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial. Finke J; Schmoor C; Bethge WA; Ottinger HD; Stelljes M; Zander AR; Volin L; Heim DA; Schwerdtfeger R; Kolbe K; Mayer J; Maertens JA; Linkesch W; Holler E; Koza V; Bornhäuser M; Einsele H; Bertz H; Grishina O; Socié G; Biol Blood Marrow Transplant; 2012 Nov; 18(11):1716-26. PubMed ID: 22713691 [TBL] [Abstract][Full Text] [Related]
32. Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Loren AW; Bunin GR; Boudreau C; Champlin RE; Cnaan A; Horowitz MM; Loberiza FR; Porter DL Biol Blood Marrow Transplant; 2006 Jul; 12(7):758-69. PubMed ID: 16785065 [TBL] [Abstract][Full Text] [Related]
34. Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. Eisner MD; August CS Bone Marrow Transplant; 1995 May; 15(5):663-8. PubMed ID: 7670393 [TBL] [Abstract][Full Text] [Related]
35. Long-Term Recipient Health-Related Quality of Life and Donor-Recipient Relationship following Sibling Pediatric Hematopoietic Stem Cell Transplantation. Zając-Spychała O; Pieczonka A; Barańska M; Wachowiak J Biol Blood Marrow Transplant; 2020 Feb; 26(2):401-406. PubMed ID: 31622770 [TBL] [Abstract][Full Text] [Related]
36. UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation. Santos N; Rodríguez-Romanos R; Nieto JB; Buño I; Vallejo C; Jiménez-Velasco A; Brunet S; Buces E; López-Jiménez J; González M; Ferrá C; Sampol A; de la Cámara R; Martínez C; Gallardo D; Bone Marrow Transplant; 2016 Jan; 51(1):79-82. PubMed ID: 26367234 [TBL] [Abstract][Full Text] [Related]
37. [Single center comparative analysis of hematopoietic cell transplantation from alternated donor in patients with hematologic malignancies]. Wang J; Zhou J; Zheng HF; Wang PF; Fu CC Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):159-65. PubMed ID: 25687066 [TBL] [Abstract][Full Text] [Related]
38. Premature cyclosporine cessation and TBI-containing conditioning regimen increase the risk of acute GvHD in children undergoing unrelated donor hematopoietic stem cell transplantation. Szmit Z; Kałwak K; Król A; Mielcarek-Siedziuk M; Salamonowicz M; Frączkiewicz J; Ussowicz M; Owoc-Lempach J; Gorczyńska E Adv Clin Exp Med; 2019 Sep; 28(9):1185-1192. PubMed ID: 31430073 [TBL] [Abstract][Full Text] [Related]
39. The association of HLA antigen and GVHD in allogeneic hemopoietic stem cell transplantation with histocompatible sibling donor: a single-center experience in Korea. Kim HJ; Park SJ; Im HW; Kim DW; Min WS; Kim HK; Kim WI; Kim KS; Kim CC Int J Hematol; 2002 Oct; 76(3):267-71. PubMed ID: 12416738 [TBL] [Abstract][Full Text] [Related]
40. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]. Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]